Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001771814-25-000005
Filing Date
2025-12-01
Accepted
2025-12-01 18:11:59
Documents
1
Period of Report
2025-11-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1764630716.html 4  
1 FORM 4 wk-form4_1764630716.xml 4 6538
  Complete submission text file 0001771814-25-000005.txt   8059
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Issuer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O PROVENTION BIO, INC. P.O. BOX 666 OLDWICK NJ 08858
Business Address
Bluestone Jeffrey (Reporting) CIK: 0001771814 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19731 | Film No.: 251541060